Keep your ADC programs on Target | CellCarta
Our experts harness our comprehensive suite of precision assays to measure what matters throughout your ADC development. Navigate the complexities of ADC development and approval with our scientific & regulatory expertise.
Discover our ADC expertise. Request a consult today.
On Target:
Our multiplatform approach for reliable ADC analysis ensures you have a complete understanding of your target expression, engagement and ADC pharmacokinetics at all stages of development.
Download the resource
Beyond the target:
In-depth monitoring of the tumor microenvironment (TME) is crucial to understanding why patients may or may not respond to ADCs. We assess immune cell infiltration, activation and exhaustion with multiplatform approaches, plus spatial distribution of cells and targets including both transcriptomic and proteomic profiling.
On-target, off-tumor:
We understand that safety is key. Precisely assessing on-target, off-tumor ADC toxicity identifies concerns early.
On track for approval:
We conduct all assays using CAP/CLIA-accredited laboratories, ensuring the highest standards for regulatory compliance. Our team supports your pathway to approval with extensive knowledge on IVDR and HGRAC regulations.
See how we can support your ADC development. Request a consult with our ADC experts!
Streamline your ADC development with our additional benefits:
- Comprehensive worry free sample management
- A global footprint
- CDx development expertise supported by deep regulatory knowledge
Contact our experts to advance your ADC programs today!
Keep your ADC programs on Target | CellCarta
Our experts harness our comprehensive suite of precision assays to measure what matters throughout your ADC development. Navigate the complexities of ADC development and approval with our scientific & regulatory expertise.
Discover our ADC expertise. Request a consult today.
On Target:
Our multiplatform approach for reliable ADC analysis ensures you have a complete understanding of your target expression, engagement and ADC pharmacokinetics at all stages of development.
Download the resource
Beyond the target:
In-depth monitoring of the tumor microenvironment (TME) is crucial to understanding why patients may or may not respond to ADCs. We assess immune cell infiltration, activation and exhaustion with multiplatform approaches, plus spatial distribution of cells and targets including both transcriptomic and proteomic profiling.
On-target, off-tumor:
We understand that safety is key. Precisely assessing on-target, off-tumor ADC toxicity identifies concerns early.
On track for approval:
We conduct all assays using CAP/CLIA-accredited laboratories, ensuring the highest standards for regulatory compliance. Our team supports your pathway to approval with extensive knowledge on IVDR and HGRAC regulations.
See how we can support your ADC development. Request a consult with our ADC experts!
Streamline your ADC development with our additional benefits:
- Comprehensive worry free sample management
- A global footprint
- CDx development expertise supported by deep regulatory knowledge
Contact our experts to advance your ADC programs today!
